paclitaxel has been researched along with Coronary Vasospasm in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cinçin, A; Değertekin, M; Gemici, G; Oktay, A | 1 |
| Kim, JW; Oh, DJ; Park, CG; Seo, HS | 1 |
| Cocchia, R; Cook, S; Hess, OM; Meier, B; Räber, L; Togni, M; Wenaweser, P; Windecker, S | 1 |
3 other study(ies) available for paclitaxel and Coronary Vasospasm
| Article | Year |
|---|---|
Paclitaxel-induced ST-segment elevations.
Topics: Acute Coronary Syndrome; Administration, Sublingual; Angina Pectoris; Angioplasty, Balloon, Coronary; Antineoplastic Agents, Phytogenic; Biomarkers; Carcinoma; Coronary Angiography; Coronary Vasospasm; Creatine Kinase, MB Form; Electrocardiography; Female; Humans; Infusions, Intravenous; Middle Aged; Nitroglycerin; Ovarian Neoplasms; Paclitaxel; Stents; Treatment Outcome; Troponin T; Vasodilator Agents | 2009 |
Delayed severe multivessel spasm and aborted sudden death after Taxus stent implantation.
Topics: Blood Vessel Prosthesis; Coronary Stenosis; Coronary Vasospasm; Death, Sudden, Cardiac; Delayed-Action Preparations; Drug Implants; Female; Humans; Middle Aged; Nitroglycerin; Paclitaxel; Risk Factors; Stents; Vasodilator Agents | 2005 |
Local vascular dysfunction after coronary paclitaxel-eluting stent implantation.
Topics: Administration, Sublingual; Antineoplastic Agents, Phytogenic; Blood Vessel Prosthesis Implantation; Coated Materials, Biocompatible; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Coronary Vasospasm; Diagnosis, Differential; Electrocardiography; Exercise Test; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nitroglycerin; Paclitaxel; Postoperative Complications; Stents; Time Factors; Treatment Outcome; Vasoconstriction; Vasodilator Agents | 2007 |